All In Biotech

Drug Trial Radar · NCT05814926

GP681 in Volunteers With Hepatic Impairment Compared With Healthy Volunteers

Pharmacokinetics, Safety and Tolerability of GP681 Single Oral Dose in Male and Female Patients With Different Degrees of Hepatic Impairment (Child-Pugh Classification A and B) as Compared With GP681 Administration to Male and Female Healthy Subjects

Last checked: Nov 19, 2026Latest source record: Nov 15, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

24

Actual

Start

Apr 26, 2023

Primary completion

Aug 3, 2023

Study completion Oct 20, 2023

Sponsor

Sponsor type
Industry
First posted
Apr 18, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 68 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The primary objective of this study is to test whether mild (Child-Pugh A, score 5-6) and moderate (Child-Pugh B, score 7-9) hepatic impairment affects pharmacokinetics, safety and tolerability of GP681, compared with a control group with normal hepatic function following oral administration of GP681 as single dose.

Conditions

  • Healthy Volunteers
  • Hepatic Impairment

Interventions

  • GP681Drug

    GP681, tablet, oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Peak plasma concentration (Cmax) of the analyte in plasma after oral administration of GP681Time frame: Day 1 to Day12
  2. Area under the concentration-time curve of the analyte in plasma over the time interval from 0 to the last quantifiable drug plasma concentration after oral administration of GP681Time frame: Day 1 to Day12
  3. Area under the concentration-time curve of the analyte in plasma over the time interval from 0 extrapolated to infinity after oral administration of GP681Time frame: Day 1 to Day12

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Beijing You'an Hospital, Beijing Medical University

    Beijing, Beijing Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.